• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, COSTA RICA LTDA (CVD) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, COSTA RICA LTDA (CVD) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-27A
Device Problems Calcified (1077); Material Perforation (2205); Obstruction of Flow (2423)
Patient Problems Calcium Deposits/Calcification (1758); Endocarditis (1834); Heart Failure (2206); Hemolytic Anemia (2279)
Event Date 05/13/2020
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in the final report.
 
Event Description
On an unknown date in 2012, a 27mm trifecta was implanted.On (b)(6) 2018, it was observed from echo that there were structural valve degeneration due to calcification.The peak gradient was 56mmhg, with ejection fraction of 40 - 45% and lv over 6cm.The patient experienced several heart failure episodes and hemolytic anemia last year.On (b)(6) 2020, the device was explanted.The device was replaced with another aortic valve.During the aortic valve replacement operation, it was observed that the non-coronary and left coronary cusps were fused in a closed position, and there was a hole in the right coronary cusp with degenerative changed.The trifecta valve was explanted and replaced with a 25mm on-x valve.This was suspected due to chronic endocarditis and old abscess in the right coronary cusp.
 
Manufacturer Narrative
Additional information for d10, g4, g7, h2, h3, h6, and h10.Explant was reported due to calcification.The investigation found that all three leaflets were fibrotically thickened, contained tears, and had calcifications.The calcifications immobilized the leaflets.There was fibrous pannus ingrowth on the inflow surface of leaflets 1 and 2 and on the outflow of leaflet 1.No inflammation was present.The cause of the tears could not be conclusively determined; however, all of the tears were associated with calcifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, COSTA RICA LTDA (CVD)
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 01897 -405
CS  01897-4050
MDR Report Key10118322
MDR Text Key193946158
Report Number3008452825-2020-00266
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Replace
Type of Report Initial,Followup
Report Date 08/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/04/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberTF-27A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/04/2020
Was the Report Sent to FDA? No
Date Manufacturer Received08/05/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age53 YR
-
-